Skip to content

PERFORMANCE OF STOOL AND SERUM CYTOMEGALOVIRUS REAL-TIME POLYMERASE CHAIN REACTION AND THEIR COMBINATION IN DIAGNOSING CMV COLITIS

PERFORMANCE OF STOOL AND SERUM CYTOMEGALOVIRUS REAL-TIME POLYMERASE CHAIN REACTION AND THEIR COMBINATION IN DIAGNOSING CMV COLITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220828001
Enrollment
143
Registered
2022-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients older than 18 years with clinical suspicion of CMV colitis were enrolled. The criteria for clinically suspicious of CMV colitis included: i) presence of at least one of the risk factors, including human immunodeficiency virus infection, solid organ or hematologic stem cell transplantations, hematologic malignancy, inflammatory bowel disease, taking immunosuppressive agents or chemotherapy, and critically ill with multiple comorbidities, and ii) presenting with gastrointestinal tract

Interventions

Patients with the detection of either cytomegalic cells or IHC-CMV cells were diagnosed with CMV colitis.,Patients older than 18 years with clinical suspicion of CMV colitis but negative biopsy for CM
Diagnostic,Diagnostic,Diagnostic
CMV colitis,Non-CMV colitis ,Healthy volunteers

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients older than 18 years with clinical suspicion of CMV colitis were enrolled. The criteria for clinically suspicious of CMV colitis included: i) presence of at least one of the risk factors, including human immunodeficiency virus infection, solid organ or hematologic stem cell transplantations, hematologic malignancy, inflammatory bowel disease, taking immunosuppressive agents or chemotherapy, and critically ill with multiple comorbidities, and ii) presenting with gastrointestinal tract symptoms, including abdominal pain, gastrointestinal bleeding, diarrhea, and bowel ileus.

Exclusion criteria

Exclusion criteria: Patients who cannot undergo colonoscopy.

Design outcomes

Primary

MeasureTime frame
Diagnostic performance After colonoscopy Sensitivity, Specificity

Secondary

MeasureTime frame
Correlation between stool, serum, tissue CMV-PCR At diagnosis Pearson correlation

Countries

Thailand

Contacts

Public ContactOnuma Sattayalertyanyong

Faculty of Medicine Siriraj Hospital, Mahidol University

onuma.gimed@gmail.com66816165389

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026